Terms: = Colorectal cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Clinical Outcome
4 results:
1. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
[TBL] [Abstract] [Full Text] [Related]
2. Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Murgioni S; Rossini D; Marmorino F; Mennitto A; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Yamaguchi T; Loupakis F; Lenz HJ
Ann Oncol; 2017 May; 28(5):1015-1022. PubMed ID: 28453695
[TBL] [Abstract] [Full Text] [Related]
3. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma.
Lin M; Eng C; Hawk ET; Huang M; Lin J; Gu J; Ellis LM; Wu X
Cancer; 2012 Dec; 118(24):6188-98. PubMed ID: 22673945
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
[TBL] [Abstract] [Full Text] [Related]
